Moreover, our results showed that astrocytomas are enriched with immune cells expressing high levels of TMIGD2, unlike oligodendrogliomas and glioblastomas subtypes (p= 0.0091; p= 0.0006) (Figure 3M). The gene discussed is TMIGD2; the disease is astrocytoma (excluding glioblastoma).